Skip to main content
Premium Trial:

Request an Annual Quote

Incogen Wins $2M Award from National Institute for Standards and Technology

NEW YORK, July 30 – Incogen received a $2 million grant from the National Institute for Standards and Technology to develop and implement a homogenous protocol based on XML and web services technology, the company announced.

The grant comes under NIST’s Advanced Technology Program, and is meant to support the technology to provide scientists with easy access to various tools used in genomics research.

“The lack of interoperable tools and data integration has long been a thorn in the sides of both bioinformaticists and biologists,” Maciek Sasinowski, CEO of Incogen, said in a statement. “We’re quite excited and grateful that an organization like NIST realizes the scope of the challenge and agrees that our proposed approach provides the community with the best attempt to solve that problem.”

Incogen, based in Clemson, South Carolina, is active in the Interoperable Informatics Infrastructure Consortium. I3C was proposed in February by Sun Microsystems, the Biotechnology Industry Organization, the National Cancer Institute, and several commercial bioinformatics vendors to support an industry-wide effort to develop an open platform for the life sciences. The collaboration currently has 47 participants, including Affymetrix, AP Biotech, DoubleTwist, the European Bioinformatics Institute, Gene Logic, IBM, Incyte, LabBook, Millennium Pharmaceuticals, the National Cancer Institute, Oracle, and the Whitehead Institute. 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more